ZMYM4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.337150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.809000E-01
Normal-vs-Stage2
1.582550E-01
Normal-vs-Stage3
1.980220E-03
Normal-vs-Stage4
3.643400E-01
Stage1-vs-Stage2
4.842400E-01
Stage1-vs-Stage3
2.675900E-02
Stage1-vs-Stage4
7.887000E-01
Stage2-vs-Stage3
4.973800E-02
Stage2-vs-Stage4
8.227600E-01
Stage3-vs-Stage4
1.077350E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.155370E-01
Normal-vs-AfricanAmerican
7.607200E-01
Normal-vs-Asian
7.599700E-02
Caucasian-vs-AfricanAmerican
1.309980E-01
Caucasian-vs-Asian
4.129200E-01
AfricanAmerican-vs-Asian
1.458760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.241640E-01
Normal-vs-Female
1.585370E-01
Male-vs-Female
3.959400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.099000E-01
Normal-vs-Age(41-60Yrs)
3.171600E-01
Normal-vs-Age(61-80Yrs)
9.412000E-02
Normal-vs-Age(81-100Yrs)
4.059700E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.657200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.535000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.438600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.083000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.683930E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.172800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.693800E-02
Normal-vs-Daily Drinker
9.541800E-02
Normal-vs-Weekly Drinker
4.604100E-02
Normal-vs-Occasional Drinker
9.680000E-02
Normal-vs-Social Drinker
3.517000E-01
Non Drinker-vs-Daily Drinker
9.578000E-01
Non Drinker-vs-Weekly Drinker
7.727600E-01
Non Drinker-vs-Occasional Drinker
2.062000E-01
Non Drinker-vs-Social Drinker
6.752100E-02
Daily Drinker-vs-Weekly Drinker
8.408600E-01
Daily Drinker-vs-Occasional Drinker
2.660000E-01
Daily Drinker-vs-Social Drinker
1.128750E-01
Weekly Drinker-vs-Occasional Drinker
1.681830E-01
Weekly Drinker-vs-Social Drinker
7.827600E-02
Occasional Drinker-vs-Social Drinker
4.520200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.446450E-01
Normal-vs-Grade 2
3.132300E-02
Normal-vs-Grade 3
2.311700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.203000E-01
Grade 1-vs-Grade 3
2.361600E-01
Grade 1-vs-Grade 4
1.446450E-01
Grade 2-vs-Grade 3
9.253400E-01
Grade 2-vs-Grade 4
3.132300E-02
Grade 3-vs-Grade 4
2.311700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.127800E-02
Normal-vs-NonDiabetic
9.915900E-02
Diabetic-vs-NonDiabetic
1.970200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.919800E-01
Normal-vs-NoPancreatitis
7.116000E-02
Pancreatitis-vs-NoPancreatitis
3.723400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.238830E-01
Normal-vs-N1
1.590770E-01
N0-vs-N1
2.540600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.249400E-01
Normal-vs-TP53-NonMutant
3.558600E-01
TP53-Mutant-vs-TP53-NonMutant
6.947000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
